Cole Hugh M
Chief Operating Officer at Jounce Therapeutics, Inc.; SVP, Chief Business Officer at ARIAD PHARMACEUTICALS INC
- Sold, on record
- $425k
- Dollars the filings state
- Form 4 sales
- 8
- Latest Jan 10, 2023
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- Jounce Therapeutics, Inc.Chief Operating Officer
- ARIAD PHARMACEUTICALS INCSVP, Chief Business Officer
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- Jounce Therapeutics, Inc.57,668 shares
- ARIAD PHARMACEUTICALS INC6,012 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale ARIAD PHARMACEUTICALS INCPlan not statedJun 28, 2016 2016
Sold 6,012 shares at $7.05 ($42k)
Cole Hugh M, SVP, Chief Business Officer
Sold 16.7% of holdings ($253k position)29,916 shares leftFirst sale on recordFiling
- 2 Form 4 sale Jounce Therapeutics, Inc.Plan not statedAug 16, 2019 +1144 days
Sold 2,336 shares at $3.99 ($9k)
Cole Hugh M, Chief Business Officer
Sold 6.1% of holdings ($154k position)36,214 shares leftFirst sale on recordFiling
- 3 Form 4 sale Jounce Therapeutics, Inc.Plan not statedJan 7, 2020 +144 days
Sold 2,624 shares at $7.78 ($20k)
Cole Hugh M, Chief Business Officer
Sold 7.2% of holdings ($282k position)33,590 shares leftFiling
- 4 Form 4 sale Jounce Therapeutics, Inc.Plan not statedAug 18, 2020 +224 days
Sold 2,182 shares at $4.71 ($10k)
Cole Hugh M, Chief Business Officer
Sold 3.4% of holdings ($299k position)61,408 shares leftFiling
- 5 Form 4 sale Jounce Therapeutics, Inc.Plan not statedJan 8, 2021 +143 days
Sold 6,219 shares at $6.89 ($43k)
Cole Hugh M, Chief Business Officer
Sold 10.1% of holdings ($423k position)55,189 shares left2.7x usual sizeFiling
- 6 Form 4 sale Jounce Therapeutics, Inc.UnusualJan 22, 2021 +14 days
Sold 18,000 shares at $11.95 ($215k)
Cole Hugh M, Chief Business Officer
Sold 27.6% of holdings ($779k position)47,189 shares left7.3x usual sizeFiling
- 7 Form 4 sale Jounce Therapeutics, Inc.Plan not statedJan 10, 2022 +353 days
Sold 9,673 shares at $6.88 ($67k)
Cole Hugh M, Chief Business Officer
Sold 13.1% of holdings ($509k position)64,216 shares left1.6x usual sizeFiling
- 8 Form 4 sale Jounce Therapeutics, Inc.Plan not statedJan 10, 2023 +365 days
Sold 16,634 shares at $1.11 ($18k)
Cole Hugh M, Chief Operating Officer
Sold 13.1% of holdings ($141k position)110,082 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (8)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 10, 2023 | Jan 11, 2023 | Jounce Therapeutics, Inc. | Chief Operating Officer | Form 4 sale | 16,634 | $18k | 13.1% | Plan not stated | SEC |
| Jan 10, 2022 | Jan 11, 2022 | Jounce Therapeutics, Inc. | Chief Business Officer | Form 4 sale | 9,673 | $67k | 13.1% | Plan not stated | SEC |
| Jan 22, 2021 | Jan 25, 2021 | Jounce Therapeutics, Inc. | Chief Business Officer | Form 4 sale | 18,000 | $215k | 27.6% | Unusual | SEC |
| Jan 8, 2021 | Jan 11, 2021 | Jounce Therapeutics, Inc. | Chief Business Officer | Form 4 sale | 6,219 | $43k | 10.1% | Plan not stated | SEC |
| Aug 18, 2020 | Aug 18, 2020 | Jounce Therapeutics, Inc. | Chief Business Officer | Form 4 sale | 2,182 | $10k | 3.4% | Plan not stated | SEC |
| Jan 7, 2020 | Jan 10, 2020 | Jounce Therapeutics, Inc. | Chief Business Officer | Form 4 sale | 2,624 | $20k | 7.2% | Plan not stated | SEC |
| Aug 16, 2019 | Aug 16, 2019 | Jounce Therapeutics, Inc. | Chief Business Officer | Form 4 sale | 2,336 | $9k | 6.1% | Plan not stated | SEC |
| Jun 28, 2016 | Jun 29, 2016 | ARIAD PHARMACEUTICALS INC | SVP, Chief Business Officer | Form 4 sale | 6,012 | $42k | 16.7% | Plan not stated | SEC |